Karim Saad Temsamani - 01 Jul 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role: Chief Executive Officer, Director
Signature: /s/ Jason Minio, Attorney-in-Fact
Issuer symbol: CDLX
Transactions as of: 01 Jul 2023
Net transactions value: -$156,666
Form type: 4
Filing time: 05 Jul 2023, 18:39:13 UTC
Previous filing: 12 Apr 2023
Next filing: 05 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDLX	Common Stock	Options Exercise	$0	+50,000		$0.000000	50,000	01 Jul 2023	Direct	F1
transaction	CDLX	Common Stock	Sale	$156,666	-25,574	-51%	$6.13	24,426	03 Jul 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDLX	Restricted Stock Unit	Options Exercise	$0	-50,000	-25%	$0.000000	150,000	01 Jul 2023	Common Stock	50,000		Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2	Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units ("RSUs") that vested on July 1, 2023.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.98 to $6.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon receipt, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F5	25% of the RSUs shall vest on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date.